187 related articles for article (PubMed ID: 35363600)
1. Lung Function and the Risk of Exacerbation in the β-Blockers for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease Trial.
Parekh TM; Helgeson ES; Connett J; Voelker H; Ling SX; Lazarus SC; Bhatt SP; MacDonald DM; Mkorombindo T; Kunisaki KM; Fortis S; Kaminsky D; Dransfield MT
Ann Am Thorac Soc; 2022 Oct; 19(10):1642-1649. PubMed ID: 35363600
[No Abstract] [Full Text] [Related]
2. Combined Forced Expiratory Volume in 1 Second and Forced Vital Capacity Bronchodilator Response, Exacerbations, and Mortality in Chronic Obstructive Pulmonary Disease.
Fortis S; Comellas A; Make BJ; Hersh CP; Bodduluri S; Georgopoulos D; Kim V; Criner GJ; Dransfield MT; Bhatt SP;
Ann Am Thorac Soc; 2019 Jul; 16(7):826-835. PubMed ID: 30908927
[No Abstract] [Full Text] [Related]
3. Relationships between symptoms and lung function in asthma and/or chronic obstructive pulmonary disease in a real-life setting: the NOVEL observational longiTudinal studY.
Papi A; Hughes R; Del Olmo R; Agusti A; Chipps BE; Make B; Tomaszewski E; Peres Da Costa K; Srivastava D; Vestbo J; Janson C; Burgel PR; Price D
Ther Adv Respir Dis; 2024; 18():17534666241254212. PubMed ID: 38841799
[TBL] [Abstract][Full Text] [Related]
4. A New Bronchodilator Response Grading Strategy Identifies Distinct Patient Populations.
Hansen JE; Dilektasli AG; Porszasz J; Stringer WW; Pak Y; Rossiter HB; Casaburi R
Ann Am Thorac Soc; 2019 Dec; 16(12):1504-1517. PubMed ID: 31404502
[No Abstract] [Full Text] [Related]
5. Metoprolol for the Prevention of Acute Exacerbations of COPD.
Dransfield MT; Voelker H; Bhatt SP; Brenner K; Casaburi R; Come CE; Cooper JAD; Criner GJ; Curtis JL; Han MK; Hatipoğlu U; Helgeson ES; Jain VV; Kalhan R; Kaminsky D; Kaner R; Kunisaki KM; Lambert AA; Lammi MR; Lindberg S; Make BJ; Martinez FJ; McEvoy C; Panos RJ; Reed RM; Scanlon PD; Sciurba FC; Smith A; Sriram PS; Stringer WW; Weingarten JA; Wells JM; Westfall E; Lazarus SC; Connett JE;
N Engl J Med; 2019 Dec; 381(24):2304-2314. PubMed ID: 31633896
[TBL] [Abstract][Full Text] [Related]
6. Ratio of FEV
Fortis S; Comellas AP; Bhatt SP; Hoffman EA; Han MK; Bhakta NR; Paine R; Ronish B; Kanner RE; Dransfield M; Hoesterey D; Buhr RG; Barr RG; Dolezal B; Ortega VE; Drummond MB; Arjomandi M; Kaner RJ; Kim V; Curtis JL; Bowler RP; Martinez F; Labaki WW; Cooper CB; O'Neal WK; Criner G; Hansel NN; Krishnan JA; Woodruff P; Couper D; Tashkin D; Barjaktarevic I
Chest; 2021 Jul; 160(1):94-103. PubMed ID: 33539837
[TBL] [Abstract][Full Text] [Related]
7. Differences in clinical significance of bronchodilator responses measured by forced expiratory volume in 1 second and forced vital capacity.
Choi JY; Kim SK; Lee JH; Jung KS; Yoo KH; Hwang KE; Lee JD; Kim YI; Yoon HK; Um SJ
PLoS One; 2023; 18(2):e0282256. PubMed ID: 36827406
[TBL] [Abstract][Full Text] [Related]
8. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
; ;
Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
[TBL] [Abstract][Full Text] [Related]
9. Bronchodilator Responsiveness in Tobacco-Exposed People With or Without COPD.
Fortis S; Quibrera PM; Comellas AP; Bhatt SP; Tashkin DP; Hoffman EA; Criner GJ; Han MK; Barr RG; Arjomandi M; Dransfield MB; Peters SP; Dolezal BA; Kim V; Putcha N; Rennard SI; Paine R; Kanner RE; Curtis JL; Bowler RP; Martinez FJ; Hansel NN; Krishnan JA; Woodruff PG; Barjaktarevic IZ; Couper D; Anderson WH; Cooper CB;
Chest; 2023 Mar; 163(3):502-514. PubMed ID: 36395858
[TBL] [Abstract][Full Text] [Related]
10. Clinical Significance of Bronchodilator Responsiveness Evaluated by Forced Vital Capacity in COPD: SPIROMICS Cohort Analysis.
Barjaktarevic IZ; Buhr RG; Wang X; Hu S; Couper D; Anderson W; Kanner RE; Paine Iii R; Bhatt SP; Bhakta NR; Arjomandi M; Kaner RJ; Pirozzi CS; Curtis JL; O'Neal WK; Woodruff PG; Han MK; Martinez FJ; Hansel N; Wells JM; Ortega VE; Hoffman EA; Doerschuk CM; Kim V; Dransfield MT; Drummond MB; Bowler R; Criner G; Christenson SA; Ronish B; Peters SP; Krishnan JA; Tashkin DP; Cooper CB;
Int J Chron Obstruct Pulmon Dis; 2019; 14():2927-2938. PubMed ID: 31908441
[TBL] [Abstract][Full Text] [Related]
11. Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease.
Dransfield MT; Kunisaki KM; Strand MJ; Anzueto A; Bhatt SP; Bowler RP; Criner GJ; Curtis JL; Hanania NA; Nath H; Putcha N; Roark SE; Wan ES; Washko GR; Wells JM; Wendt CH; Make BJ;
Am J Respir Crit Care Med; 2017 Feb; 195(3):324-330. PubMed ID: 27556408
[TBL] [Abstract][Full Text] [Related]
12. Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.
Keam SJ; Keating GM
Treat Respir Med; 2004; 3(4):247-68. PubMed ID: 15350163
[TBL] [Abstract][Full Text] [Related]
13. Role of the Bronchodilator Test Defined by the Forced Vital Capacity in Chronic Obstructive Pulmonary Disease Phenotyping.
Zhang X; Wu Z; Liu Y; Jiang S
Int J Chron Obstruct Pulmon Dis; 2020; 15():1199-1206. PubMed ID: 32547006
[TBL] [Abstract][Full Text] [Related]
14. β-Blockers for the prevention of acute exacerbations of chronic obstructive pulmonary disease (βLOCK COPD): a randomised controlled study protocol.
Bhatt SP; Connett JE; Voelker H; Lindberg SM; Westfall E; Wells JM; Lazarus SC; Criner GJ; Dransfield MT
BMJ Open; 2016 Jun; 6(6):e012292. PubMed ID: 27267111
[TBL] [Abstract][Full Text] [Related]
15. Annual rates of change in pre- vs. post-bronchodilator FEV1 and FVC over 4 years in moderate to very severe COPD.
Tashkin DP; Li N; Halpin D; Kleerup E; Decramer M; Celli B; Elashoff R
Respir Med; 2013 Dec; 107(12):1904-11. PubMed ID: 23972968
[TBL] [Abstract][Full Text] [Related]
16. Reversible Airflow Obstruction Predicts Future Chronic Obstructive Pulmonary Disease Development in the SPIROMICS Cohort: An Observational Cohort Study.
Buhr RG; Barjaktarevic IZ; Quibrera PM; Bateman LA; Bleecker ER; Couper DJ; Curtis JL; Dolezal BA; Han MK; Hansel NN; Krishnan JA; Martinez FJ; McKleroy W; Paine R; Rennard SI; Tashkin DP; Woodruff PG; Kanner RE; Cooper CB;
Am J Respir Crit Care Med; 2022 Sep; 206(5):554-562. PubMed ID: 35549640
[No Abstract] [Full Text] [Related]
17. Small airway dysfunction and flow and volume bronchodilator responsiveness in patients with chronic obstructive pulmonary disease.
Pisi R; Aiello M; Zanini A; Tzani P; Paleari D; Marangio E; Spanevello A; Nicolini G; Chetta A
Int J Chron Obstruct Pulmon Dis; 2015; 10():1191-7. PubMed ID: 26150710
[TBL] [Abstract][Full Text] [Related]
18. Nebulization
Lu R; Li Y; Hu C; Pan P; Zhao Q; He R
Ther Adv Respir Dis; 2023; 17():17534666231214134. PubMed ID: 38073272
[TBL] [Abstract][Full Text] [Related]
19. Spirometric changes during exacerbations of COPD: a post hoc analysis of the WISDOM trial.
Watz H; Tetzlaff K; Magnussen H; Mueller A; Rodriguez-Roisin R; Wouters EFM; Vogelmeier C; Calverley PMA
Respir Res; 2018 Dec; 19(1):251. PubMed ID: 30545350
[TBL] [Abstract][Full Text] [Related]
20. Asthma-COPD overlap syndrome (ACOS) in primary care of four Latin America countries: the PUMA study.
Montes de Oca M; Victorina Lopez Varela M; Laucho-Contreras ME; Casas A; Schiavi E; Mora JC
BMC Pulm Med; 2017 Apr; 17(1):69. PubMed ID: 28431499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
